BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms

MP21-02 TRANSLOCATION OF NUCLEAR FACTOR KAPPA B AND EXPRESSION OF CYCLOOXYGENASE-2 IS ENHANCED BY KETAMINE-INDUCED ULCERATIVE CYSTITIS IN RAT BLADDER

(2015) Yung-Shun Juan et al.   JOURNAL OF UROLOGY

Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers

(2014) Xiaoyin Ke et al.   DRUG AND ALCOHOL DEPENDENCE

Elevated Serum IgE May be Associated with Development of Ketamine Cystitis

(2014) Jia-Fong Jhang et al.   JOURNAL OF UROLOGY

Ketamine is associated with lower urinary tract signs and symptoms

(2013) R. Pal et al.   DRUG AND ALCOHOL DEPENDENCE

Biomarkers in overactive bladder

(2013) Alka A. Bhide et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation

(2013) B. Frias et al.   NEUROSCIENCE

Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells

(2012) L. A. Birder et al.   Acta Physiologica

Neurotrophin regulation of neural circuit development and function

(2012) Hyungju Park et al.   NATURE REVIEWS NEUROSCIENCE

Involvement of oxidative stress-induced ERK/JNK activation in the Cu2+/pyrrolidine dithiocarbamate complex-triggered mitochondria-regulated apoptosis in pancreatic β-cells

(2011) Chin-Ching Wu et al.   TOXICOLOGY LETTERS

Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

(2010) Valerio Ricci et al.   PSYCHOPHARMACOLOGY

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY